Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100422145C reveals a green aqueous method for amide sulfone and N-substituted imine production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115678953A details a green enzymatic route for high-purity cholesterol, offering superior isomer control and safety for reliable pharmaceutical intermediate supply chains.
Patent CN113443974A details a metal-free UV-catalyzed route to phenanthrene derivatives, offering cost reduction in electronic chemical manufacturing and high purity.
Patent CN117821355A reveals efficient enzymatic synthesis for ferulic acid. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel one-pot Friedel-Crafts route for 6-methoxy-1-tetralone. High yield, low cost, scalable steroid intermediate manufacturing avoiding toxic chromium reagents.
Novel ethanol-based route for Tegaserod Maleate. Enhances purity, reduces toxicity, and optimizes cost for API manufacturing.
Novel chiral Brønsted acid catalysis method for unnatural serine. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN107445795A reveals a visible-light photocatalytic method for fluorinated aryl blocks. Enables cost reduction in agrochemical manufacturing and high-purity supply.
Patent CN114437169B reveals a green, solvent-free ball milling method for synthesizing high-purity drospirenone intermediates, offering significant cost and supply chain advantages.
Patent CN102093166B details a scalable asymmetric synthesis of (S)-trans-1-yn-4-en-eicosan-3-ol with >97% ee, offering a reliable alternative to natural extraction for pharmaceutical applications.
Patent CN103073483A reveals a safe, high-yield route for Mepivacaine using formic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN113683571B reveals a safe, scalable route for 2-methyl-5-bromopyrimidine, replacing hazardous organometallics with stable ester substitution for reliable pharmaceutical intermediate supply.
Advanced synthesis of Peramivir via CN102372657B. Replaces expensive PtO2 and toxic HgCl2. Cost-effective, scalable API intermediate manufacturing solution.
Patent CN113354534B details a green synthesis route for D-FMC. This method ensures high purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN112300085A reveals a green, base-mediated alkenylation method using alcohols and air, offering significant cost reduction and purity advantages for pharmaceutical manufacturing.
Novel convergent route for bortezomib manufacturing ensures over 99.8 percent purity. Reduces racemization risks and simplifies hydrolysis for reliable supply chain partners.
Patent CN101186600B details a mild, non-phosphorus cyclization for flavonoids using BTC and DMF. This method offers high yields and reduced environmental impact for pharmaceutical manufacturing.
Patent CN116159594A introduces a metal-free photocatalytic route for quinazolinones. This green method offers significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN118084596B enables visible light catalytic hydrogenation of aromatic olefins. Achieve high-purity intermediates with reduced costs and mild reaction conditions for scalable manufacturing.
Patent CN115925682B reveals a safer Topiroxostat route avoiding toxic cyanides. Discover cost reduction and supply chain reliability for pharmaceutical intermediates.